Comparative studies of the antineoplastic activity of 5-hydroxy-2-formylpyridine thiosemicarbazone and its seleno-semicarbazone, guanylhydrazone and semicarbazone analogs.
D000225:Adenine / Q000378:metabolism; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002250:Carbon Radioisotopes; D003035:Cobalt; D003562:Cytidine / Q000378:metabolism; D004273:DNA, Neoplasm / Q000037:antagonists & inhibitors; D006147:Guanine / Q000494:pharmacology*; D006835:Hydrazones / Q000494:pharmacology*; D007930:Leucine / Q000378:metabolism; D008024:Ligands; D008670:Metals; D051379:Mice; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors; D010761:Phosphorus Radioisotopes; D011725:Pyridines / Q000494:pharmacology*; D012334:RNA, Neoplasm / Q000037:antagonists & inhibitors; D012264:Ribonucleotide Reductases / Q000037:antagonists & inhibitors; D012510:Sarcoma 180 / Q000378:metabolism; D012643:Selenium / Q000494:pharmacology*; D012664:Semicarbazones / Q000138:chemical synthesis / Q000494:pharmacology*; D013455:Sulfur / Q000494:pharmacology; D013882:Thiosemicarbazones / Q000494:pharmacology*; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000970:Antineoplastic Agents; D002250:Carbon Radioisotopes; D004273:DNA, Neoplasm; D006835:Hydrazones; D008024:Ligands; D008670:Metals; D009363:Neoplasm Proteins; D010761:Phosphorus Radioisotopes; D011725:Pyridines; D012334:RNA, Neoplasm; D012664:Semicarbazones; D013882:Thiosemicarbazones; D014316:Tritium; D003035:Cobalt; D003562:Cytidine; D006147:Guanine; D013455:Sulfur; D012264:Ribonucleotide Reductases; D007930:Leucine; D012643:Selenium; D000225:Adenine; D013936:Thymidine